Literature DB >> 12738375

Double-blotting: a solution to the problem of nonspecific binding of secondary antibodies in immunoblotting procedures.

Françoise Lasne1.   

Abstract

"Double-blotting" (DB) has been developed to overcome the problem of nonspecific binding of secondary antibodies in immunoblotting (IB). After it has been probed by the primary antibody, the membrane with the blotted proteins is assembled with a second blank membrane and submitted to a second blotting under acidic conditions. The primary antibody molecules are thus desorbed from their corresponding antigen and transferred onto the second membrane, whereas the antigen and the interfering proteins remain bound to the first one. The second membrane can then be probed by the secondary antibodies without the risk of nonspecific binding. This method has been developed for the study of erythropoietin (EPO) in concentrated urine since a strong nonspecific binding of biotinylated secondary antibodies to some urinary proteins is observed using classical IB protocols. However, its concept makes it usable in other applications that come up against this kind of problem.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12738375     DOI: 10.1016/s0022-1759(03)00065-6

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  3 in total

1.  Detection of continuous erythropoietin receptor activator in blood and urine in anti-doping control.

Authors:  Françoise Lasne; Laurent Martin; Jean Antoine Martin; Jacques de Ceaurriz
Journal:  Haematologica       Date:  2009-06       Impact factor: 9.941

Review 2.  Erythropoiesis-stimulating agents and other methods to enhance oxygen transport.

Authors:  S Elliott
Journal:  Br J Pharmacol       Date:  2008-03-24       Impact factor: 8.739

3.  Caspase activation, sialidase release and changes in sialylation pattern of recombinant human erythropoietin produced by CHO cells in batch and fed-batch cultures.

Authors:  Kok Hwee Chuan; Sing Fee Lim; Laurent Martin; Chee Yong Yun; Sophia O H Loh; Francoise Lasne; Zhiwei Song
Journal:  Cytotechnology       Date:  2006-09-20       Impact factor: 2.058

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.